Why the study?
Does co-existing coronary artery disease increase all-cause mortality in patients with Takotsubo cardiomyopathy?
Does co-existing coronary artery disease increase all-cause mortality in patients with Takotsubo cardiomyopathy?
Co-existing coronary artery disease in patients with Takotsubo cardiomyopathy is an independent predictor of increased all-cause mortality, suggesting that ruling out CAD should not be an absolute requirement for diagnosing TC.
Answers are grounded in this paper and cite their sources.
Co-existing CAD may identify higher-risk Takotsubo patients; leaves open whether CAD screening or targeted therapy improves outcomes.
BACKGROUND AND AIM: Takotsubo cardiomyopathy (TC) is an important differential diagnosis of coronary artery disease (CAD), mimicking acute coronary syndrome in clinical symptoms, biomarker profiles and ST-elevation in ECG. Absence of occlusive coronary disease is an essential criterion distinguishing both diseases. The aim of the study was to explore the influence of co-existing incidental CAD on poorer clinical outcomes and all-cause mortality in TC. DESIGN, METHODS AND RESULTS: Our mono-centric study cohort constituted 114 consecutive patients diagnosed with TC between 2003 and 2015. The primary endpoint was the all-cause mortality. Additionally, we compared the incidence of thromboembolic events, life-threatening arrhythmias, cardiogenic shock and in-hospital death. There was no significant difference in gender distribution or mean age in both groups. Patients diagnosed with a co-existing CAD (n = 22), had a more pronounced cardiovascular risk profile. The all-cause mortality among patients with co-existing CAD after a 2-year follow-up was higher than those diagnosed with lone TC (22.7 vs. 5.4 %, P = 0.07). In a multivariate cox regression analysis CAD (HR 3.5, 95 %CI 1.0-11.6; P = 0.04), LVEF ≤ 35% (HR 3.8, 95% CI 0.0-0.6, P = 0.01) and cardiogenic shock (HR 3.8, 95% CI 1.2-11.3; P = 0.01) were independent predictors of the primary endpoint. CONCLUSION: Our study reveals that co-existing CAD impairs the outcome in patients with TC. The diagnostic work-up for TC should therefore not necessarily hinge on ruling out CAD.
No takes yet. Share an insight, caveat, or question.
Bill et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: